Literature DB >> 17021602

Hepatitis B treatment: Lessons for the nephrologist.

S K Olsen1, R S Brown.   

Abstract

Hepatitis B affects approximately 350 million people worldwide, and an estimated 1.25 million people in the United States. Although most people infected with the virus do not develop significant hepatic disease from hepatitis B, 15-40% will develop serious complications. These complications include cirrhosis, the development of hepatocellular carcinoma , and hepatic decompensation. Patients with renal failure have increased risk of acquiring the virus through blood transfusions and contact with bodily fluids at hemodialysis centers, and of developing complications from hepatitis B virus infection. Renal transplant patients are at increased risk for exacerbations of hepatitis B with immunosuppression. Thus, it is crucial for the nephrologist to have a clear understanding of the natural history and treatment of hepatitis B, both pre- and post-renal transplant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021602     DOI: 10.1038/sj.ki.5001908

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Antiviral treatment for chronic hepatitis B in renal transplant patients.

Authors:  Ezequiel Ridruejo
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation.

Authors:  Chrysoula Pipili; Evangelos Cholongitas
Journal:  World J Hepatol       Date:  2014-05-27

3.  Peripheral Treg count and it's determinants in unsensitized and sensitized chronic kidney disease patients.

Authors:  Cansu Topal; Sadi Köksoy; Gültekin Süleymanlar; Gülşen Yakuboğlu; F Fevzi Ersoy
Journal:  Int Urol Nephrol       Date:  2013-05-15       Impact factor: 2.370

4.  Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study.

Authors:  Jing Fang; Wenge Li; Zhao Tan; Duo Li
Journal:  Int Urol Nephrol       Date:  2013-06-12       Impact factor: 2.370

5.  Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.

Authors:  Julian Stumpf; Torsten Siepmann; Tom Lindner; Claudia Karger; Jörg Schwöbel; Leona Anders; Robert Faulhaber-Walter; Jens Schewe; Heike Martin; Holger Schirutschke; Kerstin Barnett; Jan Hüther; Petra Müller; Torsten Langer; Thilo Pluntke; Kirsten Anding-Rost; Frank Meistring; Thomas Stehr; Annegret Pietzonka; Katja Escher; Simon Cerny; Hansjörg Rothe; Frank Pistrosch; Harald Seidel; Alexander Paliege; Joachim Beige; Ingolf Bast; Anne Steglich; Florian Gembardt; Friederike Kessel; Hannah Kröger; Patrick Arndt; Jan Sradnick; Kerstin Frank; Anna Klimova; René Mauer; Xina Grählert; Moritz Anft; Arturo Blazquez-Navarro; Timm H Westhoff; Ulrik Stervbo; Torsten Tonn; Nina Babel; Christian Hugo
Journal:  Lancet Reg Health Eur       Date:  2021-07-23

6.  Chapter 9: Infection-related glomerulonephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.